These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 16370410)
1. Hormone therapy for the prevention of chronic conditions in postmenopausal women. Guirguis-Blake J Am Fam Physician; 2005 Dec; 72(12):2520-2. PubMed ID: 16370410 [No Abstract] [Full Text] [Related]
2. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233 [No Abstract] [Full Text] [Related]
3. Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale. Berg AO; Am J Nurs; 2003 Jun; 103(6):83-91. PubMed ID: 12802162 [No Abstract] [Full Text] [Related]
4. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Ann Intern Med; 2005 May; 142(10):855-60. PubMed ID: 15897536 [TBL] [Abstract][Full Text] [Related]
5. Estrogen and progestogen therapy in postmenopausal women. Practice Committee of the American Society for Reproductive Medicine Fertil Steril; 2006 Nov; 86(5 Suppl 1):S75-88. PubMed ID: 17055850 [No Abstract] [Full Text] [Related]
6. [Renewing the recognition on benefit and risk of long-term hormone replacement therapy in postmenopausal women]. Zhang YW Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):487-8. PubMed ID: 14627037 [No Abstract] [Full Text] [Related]
7. Individualized therapy for osteoporosis prevention and treatment in women under 60. de Villiers TJ Climacteric; 2009 Jun; 12(3):210-2. PubMed ID: 19437197 [No Abstract] [Full Text] [Related]
8. Weighing the risks and benefits of hormone therapy. Toth S; Blanchard E; Herman L; Larson L; Léger MM; McNellis R; Quigley T; Van Dyke E JAAPA; 2003 Jun; 16(6):45-7. PubMed ID: 14968505 [No Abstract] [Full Text] [Related]
9. Health risks after cessation of postmenopausal hormone therapy. Pines A; Sturdee D; Birkhäuser M; Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782 [No Abstract] [Full Text] [Related]
10. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854 [No Abstract] [Full Text] [Related]
14. [Against medicalizing the postmenopause with HRT]. Guyot B Gynecol Obstet Fertil; 2008 Jan; 36(1):104-9. PubMed ID: 18248840 [No Abstract] [Full Text] [Related]
15. Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale. U.S. Preventive Services Task Force Ann Intern Med; 2002 Nov; 137(10):834-9. PubMed ID: 12435221 [TBL] [Abstract][Full Text] [Related]
16. Where are we with postmenopausal hormone therapy in 2005? Lam PM; Chung TK; Haines C Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243 [TBL] [Abstract][Full Text] [Related]
18. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal People. Tracer H; Haselby C Am Fam Physician; 2023 Jun; 107(6):645-646. PubMed ID: 37327170 [No Abstract] [Full Text] [Related]
19. Bone health and osteoporosis in postmenopausal women. de Villiers TJ Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):73-85. PubMed ID: 19027366 [TBL] [Abstract][Full Text] [Related]
20. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. Lee WL; Chao HT; Cheng MH; Wang PH Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]